Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility

2014-08-27 03:15:35 | BioPortfolio


Susceptibility testing is commonly employed in patients with bacterial infections in order to guide rational use of antibiotics; however, the use of antifungal susceptibility testing is limited due to lack of availability, costs, and delays in receiving results. The goals of antifungal susceptibility testing should mirror those of antibacterial susceptibility testing: to predict clinical response or failure. Additionally, susceptibility reports should be used as a guide for physicians when transitioning patients from parenteral to oral antifungal agents. Currently, it is unknown whether antifungal susceptibility testing impacts treatment decisions in hospitals that routinely perform Candida susceptibility testing. The purpose of this study is to evaluate the changes in antifungal treatment based on in vitro susceptibility reports and how these decisions affect mortality, recurrence of infection, and length of hospital stay in candidemia patients.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Blood Stream Infections


Active, not recruiting


University of Houston

Results (where available)

View Results


Published on BioPortfolio: 2014-08-27T03:15:35-0400

Clinical Trials [509 Associated Clinical Trials listed on BioPortfolio]

Defining the Intestinal Microbiota in Premature Neonates

Highly premature infants are susceptible to serious infections such as necrotizing enterocolitis (NEC) and late-onset blood stream infections (BSIs). NEC is a poorly understood, potential...

Dental Study in Cancer Patients With Central Venous Catheters

Patients who are preparing to receive chemotherapy are asked to have their teeth cleaned before starting treatment as standard of care. This research study is being done to see if having ...

A Study of MK3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus

The study investigates the efficacy and safety of MK3009 in patients with skin infections and septicemia caused by MRSA.

Central and Peripheral Venous Catheters Associated Blood Stream Infection in ICU in Assiut University

Catheter related infections (CRIs) were found to be associated with several risk factors, including patient related risk factors such as age, gender, clinical status and catheter related r...

Pediatric Ethanol Lock Therapy

This study is a double-blind crossover design to compare prophylaxis with ethanol lock therapy versus placebo lock therapy (heparin). The primary outcome measure will be the number of cath...

PubMed Articles [9857 Associated PubMed Articles listed on BioPortfolio]

Pattern Of Causative Micro-Organisms In Catheter Related Blood Stream Infections In Dialysis Patients: Experience From Saudi Arabia.

Catheter related blood stream infections (CRBSI) are the leading cause of morbidity in HD patients. The majority of these infections relate to haemodialysis catheters. There is a paucity of local data...

Pattern of Gram-negative Blood Stream Infections and their Antibiotic Susceptibility Profiles in a Neonatal Intensive Care Unit.

Transfusion and blood stream infections after coronary surgery.

The aim of this study was to evaluate the impact of blood transfusion on bloodstream infections. This study included 2764 patients who underwent isolated coronary artery bypass grafting. Blood culture...

Early Blood Stream Infection after BMT is Associated with Cytokine Dysregulation and Poor Overall Survival.

The key complications of allogeneic bone marrow transplant (BMT) remain graft-versus-host disease (GVHD) and opportunistic infection. We have analyzed the blood stream infections (BSI) occurring betwe...

ICU mortality following ICU-acquired primary bloodstream infections according to the type of pathogen: A prospective cohort study in 937 Germany ICUs (2006-2015).

Mortality due to intensive care unit (ICU) acquired primary blood stream infections (PBSI) is related primarily to patient co-morbidities, types of pathogens and quality of care. The objective of this...

Medical and Biotech [MESH] Definitions

The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)

Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.

Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.

A collective term for pathological conditions which are caused by the formation of a blood clot (THROMBUS) in a blood vessel, or by blocking of a blood vessel with an EMBOLUS, undissolved materials in the blood stream.

Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.

More From BioPortfolio on "Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility"

Quick Search


Relevant Topic

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Searches Linking to this Trial